 | • レポートコード：QYR2104Z4511 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、心膜炎のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（急性心膜炎、慢性心膜炎、再発性心膜炎）、用途別市場規模（病院＆診療所、医療機関、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・心膜炎の市場動向 ・企業の競争状況、市場シェア ・心膜炎の種類別市場規模（急性心膜炎、慢性心膜炎、再発性心膜炎） ・心膜炎の用途別市場規模（病院＆診療所、医療機関、研究機関） ・心膜炎の北米市場規模2016-2027（アメリカ、カナダ） ・心膜炎のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・心膜炎のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・心膜炎の中南米市場規模2016-2027（メキシコ、ブラジル） ・心膜炎の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Astrazeneca、Bayer、Reckitt Benckiser、Perkinelmer、Fujifilm、Merck Sharp & Dohme、Allergan） ・結論 |
Pericarditis is inflammation of the pericardium (the fibrous sac surrounding the heart). Symptoms typically include sudden onset of sharp chest pain. The pain may also be felt in the shoulders, neck, or back. It is typically better sitting up and worse with lying down or breathing deep. Other symptoms may include fever, weakness, palpitations, and shortness of breath. Occasionally onset of symptoms is gradual.
Treatment in most cases is with NSAIDs and possibly colchicine. Steroids may be used if those are not appropriate. Typically symptoms improve in a few days to weeks but can occasionally last months. Complications can include cardiac tamponade, myocarditis, and constrictive pericarditis. It is a less common cause of chest pain. About 3 per 10,000 people are affected per year. Those most commonly affected are males between the ages of 20 and 50. Up to 30% of those affected have more than one episode.
Market Analysis and Insights: Global Pericarditis Market
The global Pericarditis market size is projected to reach US$ 2634.6 million by 2026, from US$ 1927.5 million in 2019, at a CAGR of 4.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pericarditis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pericarditis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pericarditis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pericarditis market.
Global Pericarditis Scope and Market Size
Pericarditis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pericarditis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Acute Pericarditis
Chronic Pericarditis
Recurrent Pericarditis
Segment by Application
Hospitals & Clinics
Medical Institutes
Research Organization
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Astrazeneca
Bayer
Reckitt Benckiser
Perkinelmer
Fujifilm
Merck Sharp & Dohme
Allergan
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pericarditis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acute Pericarditis
1.2.3 Chronic Pericarditis
1.2.4 Recurrent Pericarditis
1.3 Market by Application
1.3.1 Global Pericarditis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinics
1.3.3 Medical Institutes
1.3.4 Research Organization
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pericarditis Market Perspective (2016-2027)
2.2 Pericarditis Growth Trends by Regions
2.2.1 Pericarditis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pericarditis Historic Market Share by Regions (2016-2021)
2.2.3 Pericarditis Forecasted Market Size by Regions (2022-2027)
2.3 Pericarditis Industry Dynamic
2.3.1 Pericarditis Market Trends
2.3.2 Pericarditis Market Drivers
2.3.3 Pericarditis Market Challenges
2.3.4 Pericarditis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pericarditis Players by Revenue
3.1.1 Global Top Pericarditis Players by Revenue (2016-2021)
3.1.2 Global Pericarditis Revenue Market Share by Players (2016-2021)
3.2 Global Pericarditis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pericarditis Revenue
3.4 Global Pericarditis Market Concentration Ratio
3.4.1 Global Pericarditis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pericarditis Revenue in 2020
3.5 Pericarditis Key Players Head office and Area Served
3.6 Key Players Pericarditis Product Solution and Service
3.7 Date of Enter into Pericarditis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pericarditis Breakdown Data by Type
4.1 Global Pericarditis Historic Market Size by Type (2016-2021)
4.2 Global Pericarditis Forecasted Market Size by Type (2022-2027)
5 Pericarditis Breakdown Data by Application
5.1 Global Pericarditis Historic Market Size by Application (2016-2021)
5.2 Global Pericarditis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pericarditis Market Size (2016-2027)
6.2 North America Pericarditis Market Size by Type
6.2.1 North America Pericarditis Market Size by Type (2016-2021)
6.2.2 North America Pericarditis Market Size by Type (2022-2027)
6.2.3 North America Pericarditis Market Size by Type (2016-2027)
6.3 North America Pericarditis Market Size by Application
6.3.1 North America Pericarditis Market Size by Application (2016-2021)
6.3.2 North America Pericarditis Market Size by Application (2022-2027)
6.3.3 North America Pericarditis Market Size by Application (2016-2027)
6.4 North America Pericarditis Market Size by Country
6.4.1 North America Pericarditis Market Size by Country (2016-2021)
6.4.2 North America Pericarditis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pericarditis Market Size (2016-2027)
7.2 Europe Pericarditis Market Size by Type
7.2.1 Europe Pericarditis Market Size by Type (2016-2021)
7.2.2 Europe Pericarditis Market Size by Type (2022-2027)
7.2.3 Europe Pericarditis Market Size by Type (2016-2027)
7.3 Europe Pericarditis Market Size by Application
7.3.1 Europe Pericarditis Market Size by Application (2016-2021)
7.3.2 Europe Pericarditis Market Size by Application (2022-2027)
7.3.3 Europe Pericarditis Market Size by Application (2016-2027)
7.4 Europe Pericarditis Market Size by Country
7.4.1 Europe Pericarditis Market Size by Country (2016-2021)
7.4.2 Europe Pericarditis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pericarditis Market Size (2016-2027)
8.2 Asia-Pacific Pericarditis Market Size by Type
8.2.1 Asia-Pacific Pericarditis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pericarditis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pericarditis Market Size by Type (2016-2027)
8.3 Asia-Pacific Pericarditis Market Size by Application
8.3.1 Asia-Pacific Pericarditis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pericarditis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pericarditis Market Size by Application (2016-2027)
8.4 Asia-Pacific Pericarditis Market Size by Region
8.4.1 Asia-Pacific Pericarditis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pericarditis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pericarditis Market Size (2016-2027)
9.2 Latin America Pericarditis Market Size by Type
9.2.1 Latin America Pericarditis Market Size by Type (2016-2021)
9.2.2 Latin America Pericarditis Market Size by Type (2022-2027)
9.2.3 Latin America Pericarditis Market Size by Type (2016-2027)
9.3 Latin America Pericarditis Market Size by Application
9.3.1 Latin America Pericarditis Market Size by Application (2016-2021)
9.3.2 Latin America Pericarditis Market Size by Application (2022-2027)
9.3.3 Latin America Pericarditis Market Size by Application (2016-2027)
9.4 Latin America Pericarditis Market Size by Country
9.4.1 Latin America Pericarditis Market Size by Country (2016-2021)
9.4.2 Latin America Pericarditis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pericarditis Market Size (2016-2027)
10.2 Middle East & Africa Pericarditis Market Size by Type
10.2.1 Middle East & Africa Pericarditis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pericarditis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pericarditis Market Size by Type (2016-2027)
10.3 Middle East & Africa Pericarditis Market Size by Application
10.3.1 Middle East & Africa Pericarditis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pericarditis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pericarditis Market Size by Application (2016-2027)
10.4 Middle East & Africa Pericarditis Market Size by Country
10.4.1 Middle East & Africa Pericarditis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pericarditis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Pericarditis Introduction
11.1.4 Pfizer Revenue in Pericarditis Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Astrazeneca
11.2.1 Astrazeneca Company Details
11.2.2 Astrazeneca Business Overview
11.2.3 Astrazeneca Pericarditis Introduction
11.2.4 Astrazeneca Revenue in Pericarditis Business (2016-2021)
11.2.5 Astrazeneca Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Pericarditis Introduction
11.3.4 Bayer Revenue in Pericarditis Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Reckitt Benckiser
11.4.1 Reckitt Benckiser Company Details
11.4.2 Reckitt Benckiser Business Overview
11.4.3 Reckitt Benckiser Pericarditis Introduction
11.4.4 Reckitt Benckiser Revenue in Pericarditis Business (2016-2021)
11.4.5 Reckitt Benckiser Recent Development
11.5 Perkinelmer
11.5.1 Perkinelmer Company Details
11.5.2 Perkinelmer Business Overview
11.5.3 Perkinelmer Pericarditis Introduction
11.5.4 Perkinelmer Revenue in Pericarditis Business (2016-2021)
11.5.5 Perkinelmer Recent Development
11.6 Fujifilm
11.6.1 Fujifilm Company Details
11.6.2 Fujifilm Business Overview
11.6.3 Fujifilm Pericarditis Introduction
11.6.4 Fujifilm Revenue in Pericarditis Business (2016-2021)
11.6.5 Fujifilm Recent Development
11.7 Merck Sharp & Dohme
11.7.1 Merck Sharp & Dohme Company Details
11.7.2 Merck Sharp & Dohme Business Overview
11.7.3 Merck Sharp & Dohme Pericarditis Introduction
11.7.4 Merck Sharp & Dohme Revenue in Pericarditis Business (2016-2021)
11.7.5 Merck Sharp & Dohme Recent Development
11.8 Allergan
11.8.1 Allergan Company Details
11.8.2 Allergan Business Overview
11.8.3 Allergan Pericarditis Introduction
11.8.4 Allergan Revenue in Pericarditis Business (2016-2021)
11.8.5 Allergan Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pericarditis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acute Pericarditis
Table 3. Key Players of Chronic Pericarditis
Table 4. Key Players of Recurrent Pericarditis
Table 5. Global Pericarditis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pericarditis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pericarditis Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pericarditis Market Share by Regions (2016-2021)
Table 9. Global Pericarditis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pericarditis Market Share by Regions (2022-2027)
Table 11. Pericarditis Market Trends
Table 12. Pericarditis Market Drivers
Table 13. Pericarditis Market Challenges
Table 14. Pericarditis Market Restraints
Table 15. Global Pericarditis Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pericarditis Market Share by Players (2016-2021)
Table 17. Global Top Pericarditis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pericarditis as of 2020)
Table 18. Ranking of Global Top Pericarditis Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pericarditis Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pericarditis Product Solution and Service
Table 22. Date of Enter into Pericarditis Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pericarditis Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pericarditis Revenue Market Share by Type (2016-2021)
Table 26. Global Pericarditis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pericarditis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pericarditis Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pericarditis Revenue Market Share by Application (2016-2021)
Table 30. Global Pericarditis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pericarditis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pericarditis Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pericarditis Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pericarditis Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pericarditis Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pericarditis Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pericarditis Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pericarditis Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pericarditis Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pericarditis Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pericarditis Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pericarditis Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pericarditis Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pericarditis Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pericarditis Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pericarditis Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pericarditis Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pericarditis Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pericarditis Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pericarditis Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pericarditis Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pericarditis Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pericarditis Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pericarditis Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pericarditis Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pericarditis Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pericarditis Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pericarditis Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pericarditis Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pericarditis Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pericarditis Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Pericarditis Product
Table 65. Pfizer Revenue in Pericarditis Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Astrazeneca Company Details
Table 68. Astrazeneca Business Overview
Table 69. Astrazeneca Pericarditis Product
Table 70. Astrazeneca Revenue in Pericarditis Business (2016-2021) & (US$ Million)
Table 71. Astrazeneca Recent Development
Table 72. Bayer Company Details
Table 73. Bayer Business Overview
Table 74. Bayer Pericarditis Product
Table 75. Bayer Revenue in Pericarditis Business (2016-2021) & (US$ Million)
Table 76. Bayer Recent Development
Table 77. Reckitt Benckiser Company Details
Table 78. Reckitt Benckiser Business Overview
Table 79. Reckitt Benckiser Pericarditis Product
Table 80. Reckitt Benckiser Revenue in Pericarditis Business (2016-2021) & (US$ Million)
Table 81. Reckitt Benckiser Recent Development
Table 82. Perkinelmer Company Details
Table 83. Perkinelmer Business Overview
Table 84. Perkinelmer Pericarditis Product
Table 85. Perkinelmer Revenue in Pericarditis Business (2016-2021) & (US$ Million)
Table 86. Perkinelmer Recent Development
Table 87. Fujifilm Company Details
Table 88. Fujifilm Business Overview
Table 89. Fujifilm Pericarditis Product
Table 90. Fujifilm Revenue in Pericarditis Business (2016-2021) & (US$ Million)
Table 91. Fujifilm Recent Development
Table 92. Merck Sharp & Dohme Company Details
Table 93. Merck Sharp & Dohme Business Overview
Table 94. Merck Sharp & Dohme Pericarditis Product
Table 95. Merck Sharp & Dohme Revenue in Pericarditis Business (2016-2021) & (US$ Million)
Table 96. Merck Sharp & Dohme Recent Development
Table 97. Allergan Company Details
Table 98. Allergan Business Overview
Table 99. Allergan Revenue in Pericarditis Business (2016-2021) & (US$ Million)
Table 100. Allergan Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pericarditis Market Share by Type: 2020 VS 2027
Figure 2. Acute Pericarditis Features
Figure 3. Chronic Pericarditis Features
Figure 4. Recurrent Pericarditis Features
Figure 5. Global Pericarditis Market Share by Application: 2020 VS 2027
Figure 6. Hospitals & Clinics Case Studies
Figure 7. Medical Institutes Case Studies
Figure 8. Research Organization Case Studies
Figure 9. Pericarditis Report Years Considered
Figure 10. Global Pericarditis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Pericarditis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pericarditis Market Share by Regions: 2020 VS 2027
Figure 13. Global Pericarditis Market Share by Regions (2022-2027)
Figure 14. Global Pericarditis Market Share by Players in 2020
Figure 15. Global Top Pericarditis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pericarditis as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Pericarditis Revenue in 2020
Figure 17. Global Pericarditis Revenue Market Share by Type (2016-2021)
Figure 18. Global Pericarditis Revenue Market Share by Type (2022-2027)
Figure 19. North America Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Pericarditis Market Share by Type (2016-2027)
Figure 21. North America Pericarditis Market Share by Application (2016-2027)
Figure 22. North America Pericarditis Market Share by Country (2016-2027)
Figure 23. United States Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pericarditis Market Share by Type (2016-2027)
Figure 27. Europe Pericarditis Market Share by Application (2016-2027)
Figure 28. Europe Pericarditis Market Share by Country (2016-2027)
Figure 29. Germany Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pericarditis Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Pericarditis Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Pericarditis Market Share by Region (2016-2027)
Figure 39. China Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pericarditis Market Share by Type (2016-2027)
Figure 47. Latin America Pericarditis Market Share by Application (2016-2027)
Figure 48. Latin America Pericarditis Market Share by Country (2016-2027)
Figure 49. Mexico Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pericarditis Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Pericarditis Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Pericarditis Market Share by Country (2016-2027)
Figure 55. Turkey Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Pericarditis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Pericarditis Business (2016-2021)
Figure 59. Astrazeneca Revenue Growth Rate in Pericarditis Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Pericarditis Business (2016-2021)
Figure 61. Reckitt Benckiser Revenue Growth Rate in Pericarditis Business (2016-2021)
Figure 62. Perkinelmer Revenue Growth Rate in Pericarditis Business (2016-2021)
Figure 63. Fujifilm Revenue Growth Rate in Pericarditis Business (2016-2021)
Figure 64. Merck Sharp & Dohme Revenue Growth Rate in Pericarditis Business (2016-2021)
Figure 65. Allergan Revenue Growth Rate in Pericarditis Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の心膜炎治療市場規模・現状・予測（2021年-2027年） Pericarditis is a cardiovascular disease which represents the swelling of the pericardium wall of the heart. The main cause of pericardium disease is the inflammation of pericardium wall which is generally caused by viral infection. Other causes of pericarditis disease are renal failure, bacterial i…- 世界の急性・慢性異常子宮出血（AUB）市場規模・現状・予測（2021年-2027年） Abnormal uterine bleeding (AUB) may be acute or chronic and is defined as bleeding from the uterine corpus that is abnormal in regularity, volume, frequency, or duration and occurs in the absence of pregnancy. Market Analysis and Insights: Global Acute and Chronic Abnormal Uterine Bleeding Market Th…
- 世界の再発性多形性膠芽腫（GBM）治療市場規模・現状・予測（2021年-2027年） Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain. The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market. Market Analysis and Insights: Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market…
- 世界の炎症性心臓病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Heart Disease Market The global Inflammatory Heart Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界のリウマチ性心臓病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Rheumatic Heart Disease Market The global Rheumatic Heart Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…